In 2013, seasonal malaria chemoprevention (SMC) was introduced in Niger in accordance with the recommendations of the World Health Organization (WHO) and the national policy to combat Malaria. Children aged 3 to 59 months received curative doses of sulphadoxine-pyrimethamine and amodiaquine once a month over a course of 3 days from July to November throughout a mass campaign.
The target group of children aged from 3 to 59 months - living in 12 health areas of five health districts (Magaria, Madaoua, Bouza, Madaraounfa and Guidam-Roumdji) spread over three regions of Niger (Zinder, Tahoua, Maradi) - was initially estimated at 139 000 children. After having repeated the population censuses in the respective districts the estimation had to be increased by 50 % reaching a total of 206 000 children in the target group.
The SMC medicine, available in combination packs containing both SP and AQ, was distributed by more than 2 000 local community agents supported by 90 supervisors. The medicine was given out in 179 large fixed sites, 75 small fixed sites and by 99 teams distributing door-to-door.
Only the OCB teams in the Guidam Roumdji district supervised the drug administration during all 3 days. In the other districts, only the intake of the first dose was supervised, the other two doses were then administered by relatives at home.